Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Goodwill & Intangibles (2023 - 2026)

TransMedics has reported Goodwill & Intangibles over the past 3 years, most recently at $13.5 million for Q4 2025.

  • For Q4 2025, Goodwill & Intangibles fell 1.49% year-over-year to $13.5 million; the TTM value through Dec 2025 reached $13.5 million, down 1.49%, while the annual FY2025 figure was $13.5 million, 1.49% down from the prior year.
  • Goodwill & Intangibles for Q4 2025 was $13.5 million at TransMedics, roughly flat from $13.5 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $14.3 million in Q4 2023 and troughed at $13.5 million in Q4 2025.
  • A 3-year average of $13.8 million and a median of $13.7 million in 2024 define the central range for Goodwill & Intangibles.
  • On a YoY basis, Goodwill & Intangibles climbed as much as 1.47% in 2025 and fell as far as 4.5% in 2025.
  • Year by year, Goodwill & Intangibles stood at $14.3 million in 2023, then dropped by 4.48% to $13.7 million in 2024, then fell by 1.49% to $13.5 million in 2025.
  • Business Quant data shows Goodwill & Intangibles for TMDX at $13.5 million in Q4 2025, $13.5 million in Q3 2025, and $13.6 million in Q2 2025.